# Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma

> **NCT02097134** · PHASE1 · COMPLETED · sponsor: **Children's Oncology Group** · enrollment: 14 (actual)

## Conditions studied

- Unilateral Retinoblastoma

## Interventions

- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT02097134
- **Lead sponsor:** Children's Oncology Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-31
- **Primary completion:** 2017-06-30
- **Final completion:** 2023-09-30
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2023-10-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02097134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02097134, "Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02097134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*